Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation Can Greatly Benefit From a Novel Once-Daily Intravenous Busulfan Dosing Nomogram

American Journal of Hematology - United States
doi 10.1002/ajh.24734

Related search